Bayer’s Final Roundup Settlement Could Cost Up to $7.25 Billion

Roundup settlement Bayer: A Missouri judge has given final approval to a nationwide settlement that could cost Bayer up to $7.25 billion over coming years. Payments to people with non-Hodgkin lymphoma linked to glyphosate range from $10,000 to $165,000, depending on exposure, age at diagnosis and other factors.

Roundup settlement Bayer, Digimart Global (United States): Bayer has agreed to pay billions of dollars to people who sued the company, alleging that its weed-killer Roundup caused their cancer. On Friday, a judge in Missouri gave final approval to the nationwide settlement, which could cost the company up to $7.25 billion in the coming years, according to NPR.

The money will go to thousands of people who have been or will be diagnosed with non-Hodgkin lymphoma, a blood cancer that claimants link to glyphosate, the main ingredient in Roundup. Under the settlement in circuit court, affected people could receive between $10,000 and $165,000. The amount depends on whether their agricultural or other work exposed them to higher levels of glyphosate, the age at which they were diagnosed and other factors.

Bayer CEO Bill Anderson called the settlement a “decisive milestone” that will “mitigate the risks” of pending and future litigation. Presiding judge Timothy Boyer said it was “among the largest in the history of mass tort personal-injury class action settlements.” The plaintiffs’ attorney, Christopher Seeger, said the order “delivers guaranteed compensation to Roundup cancer victims who have waited more than a decade for justice.”

The new agreement comes on top of an earlier settlement in which Bayer agreed to pay between about $10 billion and $11 billion to resolve more than 100,000 Roundup-related claims. Earlier this year, the U.S.

Supreme Court ruled in Bayer’s favor, finding that it could be shielded from state-court lawsuits alleging it failed to warn consumers about glyphosate’s cancer-causing effects.

The scientific and regulatory picture remains contested. More than a decade ago, the World Health Organization’s cancer agency concluded that glyphosate is probably carcinogenic to humans, and some environmental health scientists have echoed those concerns as recently as this year.

Bayer has consistently denied that its product causes cancer. The Environmental Protection Agency has said it “did not identify risks of concern from glyphosate uses, including for cancer,” but is currently reviewing the evidence related to human health.

Glyphosate safety has been an issue for supporters of Health Secretary Robert F. Kennedy Jr.

and his Make America Healthy Again agenda. The Trump administration, however, has backed the herbicide maker, siding with Bayer in the Supreme Court case and issuing an executive order to promote domestic glyphosate production.

Several years ago, the company removed glyphosate from its U.S. residential products, though it remains in use in agriculture.

James Mitchell

James Mitchell covers major U.S. developments, national affairs, public policy, and breaking news for Digimart Global. His editorial focus is on clear, accurate, and accessible reporting that helps readers understand important events across America.

Website

Leave a Reply

Your email address will not be published. Required fields are marked *

Sports

Explore Digimart Global